{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:16:53Z","timestamp":1794003413201,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5UH3HL140131"],"award-info":[{"award-number":["5UH3HL140131"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5 UG1 HD027915-29"],"award-info":[{"award-number":["5 UG1 HD027915-29"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.siny.2020.101123","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T02:10:38Z","timestamp":1591063838000},"page":"101123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Prevention of preeclampsia"],"prefix":"10.1016","volume":"25","author":[{"given":"Marwan","family":"Ma\u2019ayeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged M.","family":"Costantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib1","first-page":"80","article-title":"Geographic variation in the incidence of hypertension in pregnancy. World health organization international collaborative study of hypertensive disorders of pregnancy","volume":"158","author":"World Health Organization","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bpobgyn.2011.04.002","article-title":"Pre-eclampsia in low and middle income countries","volume":"25","author":"Firoz","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib3","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","author":"Espinoza","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib4","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","article-title":"Prediction and prevention of recurrent preeclampsia","volume":"112","author":"Barton","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.a.20512","article-title":"Recurrence risk of preeclampsia in twin and singleton pregnancies","volume":"126A","author":"Trogstad","year":"2004","journal-title":"Am J Med Genet"},{"issue":"7627","key":"10.1016\/j.siny.2020.101123_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.siny.2020.101123_bib8","first-page":"214365","article-title":"Maternal preeclampsia and neonatal outcomes","volume":"2011","author":"Backes","year":"2011","journal-title":"J\u00a0Pregnancy"},{"issue":"4","key":"10.1016\/j.siny.2020.101123_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.116.08414","article-title":"Hypertension in pregnancy and offspring cardiovascular risk in young adulthood: prospective and sibling studies in the HUNT study (Nord-Tr\u00f8ndelag health study) in Norway","volume":"69","author":"Alsnes","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.060","article-title":"Health of children born to mothers who had preeclampsia: a population-based cohort study","volume":"201","author":"Wu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib12","series-title":"Williams obstetrics","author":"Cunningham","year":"2014"},{"issue":"12","key":"10.1016\/j.siny.2020.101123_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200103223441201","article-title":"Paternal and maternal components of the predisposition to preeclampsia","volume":"344","author":"Esplin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101123_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0378(03)00044-5","article-title":"Trophoblast deportation and the maternal inflammatory response in pre-eclampsia","volume":"59","author":"Sargent","year":"2003","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.siny.2020.101123_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","article-title":"Etiology and pathogenesis of preeclampsia: current concepts","volume":"179","author":"Dekker","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ajog.2005.10.813","article-title":"Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?","volume":"194","author":"Villar","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.siny.2020.101123_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2009.03.027","article-title":"Uterine artery Doppler flow studies in obstetric practice","volume":"201","author":"Sciscione","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101123_bib19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.semperi.2014.03.005","article-title":"Pathophysiology of ischemic placental disease","volume":"38","author":"Roberts","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.siny.2020.101123_bib21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","article-title":"Preeclampsia: an imbalance in placental prostacyclin and thromboxane Production","volume":"152","author":"Walsh","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1056\/NEJM197905173002006","article-title":"Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls","volume":"300","author":"Moncada","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101123_bib25","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/pr.111.004770","article-title":"Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn","volume":"64","author":"Majed","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.siny.2020.101123_bib27","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"4","key":"10.1016\/j.siny.2020.101123_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.siny.2020.101123_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.siny.2020.101123_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.siny.2020.101123_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.18899","article-title":"Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.siny.2020.101123_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.siny.2020.101123_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/AOG.0000000000003167","article-title":"A\u00a0nudge toward universal aspirin for preeclampsia prevention","volume":"133","author":"Ayala","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.siny.2020.101123_bib35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A\u00a0cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.siny.2020.101123_bib36","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2020.101123_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1874467209666160112123457","article-title":"Statins, mevalonate pathway and its intermediate products in placental development and preeclampsia","volume":"10","author":"Caniggia","year":"2016","journal-title":"Curr Mol Pharmacol"},{"issue":"116","key":"10.1016\/j.siny.2020.101123_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/OGX.0000000000000522","article-title":"Pravastatin for preventing and treating preeclampsia: a systematic review","volume":"73","author":"Esteve-Valverde","year":"2018","journal-title":"Obstet Gynecol Surv"},{"issue":"8","key":"10.1016\/j.siny.2020.101123_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120147","article-title":"Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice","volume":"3","author":"Garrett","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.siny.2020.101123_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2010","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.siny.2020.101123_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.siny.2020.101123_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11906-020-1026-8","article-title":"Novel interventions for the prevention of preeclampsia","volume":"22","author":"Ma\u2019ayeh","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.siny.2020.101123_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.siny.2020.101123_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/14767058.2015.1022864","article-title":"Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD)","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J\u00a0Matern Neonatal Med"},{"issue":"720","key":"10.1016\/j.siny.2020.101123_bib46","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.siny.2020.101123_bib47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.siny.2020.101123_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.05.038","article-title":"Transplacental transfer and distribution of pravastatin","volume":"209","author":"Nanovskaya","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.siny.2020.101123_bib49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metabol"},{"key":"10.1016\/j.siny.2020.101123_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dme.13523","article-title":"Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis","volume":"35","author":"Alqudah","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.siny.2020.101123_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2020.101123_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.siny.2020.101123_bib54","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ajog.2006.05.047","article-title":"Transfer of metformin across the dually perfused human placental lobule","volume":"195","author":"Nanovskaya","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.siny.2020.101123_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humupd\/dmu022","article-title":"First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis","volume":"20","author":"Cassina","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.siny.2020.101123_bib56","doi-asserted-by":"crossref","first-page":"F488","DOI":"10.1136\/archdischild-2015-309602","article-title":"Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes","volume":"101","author":"Wouldes","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.siny.2020.101123_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000456","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 Years of age","volume":"6","author":"Rowan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.siny.2020.101123_bib58","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.siny.2020.101123_bib59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.siny.2020.101123_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"Am J Obstet Gynecol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X20300482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X20300482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:45:13Z","timestamp":1761677113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X20300482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1744165X20300482"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2020.101123","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2020.101123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101123"}}